Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Hold to Sell as of 2 July 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust financial performance and healthy long-term growth metrics. The downgrade reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite a strong year-to-date return of 27.5%, recent technical indicators suggest caution as the stock navigates mixed signals from key momentum oscillators and moving averages.

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with the latest insights into its performance and outlook.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has exhibited a shift from a sideways to a mildly bullish technical trend, supported by recent price momentum and select technical indicators. Despite some mixed signals from monthly and weekly oscillators, the stock’s year-to-date return of 26.23% significantly outpaces the Sensex’s negative 10.26%, signalling underlying strength in an otherwise cautious market environment.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has exhibited a nuanced shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest daily gain of 1.17%, the stock’s technical indicators present a complex picture, reflecting both resilience and caution for investors navigating the current market environment.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day decline of 0.47%, the stock’s technical indicators suggest cautious optimism, supported by a strong year-to-date return of 24.33% compared to the Sensex’s negative 9.53% over the same period.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day decline of 1.09%, the stock’s year-to-date return of 24.09% significantly outpaces the Sensex’s negative 10.58%, signalling underlying resilience amid mixed technical signals.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has exhibited a notable shift in technical momentum, moving from a sideways trend to a mildly bullish stance. Recent price action, combined with key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggests a cautiously optimistic outlook for the stock amid mixed market conditions.

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 June 2026, providing investors with the latest insights into its performance and outlook.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a year-to-date return of 25.06%, the stock’s recent price action and technical indicators suggest a period of consolidation, with mixed signals from key momentum oscillators and moving averages.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has transitioned from a sideways technical trend to a mildly bullish stance, supported by recent price momentum and technical indicator signals. The stock’s current price of ₹130.80 reflects a 1.24% gain on 16 Jun 2026, signalling renewed investor interest amid mixed broader market conditions.

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent 1.6% decline in the stock price to ₹135.35, the company’s year-to-date return of 31.7% significantly outpaces the Sensex’s negative 12.9%, signalling underlying strength amid short-term technical caution.

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has recently seen its quality grade upgraded from "Does Not Qualify" to "Average" by MarketsMOJO. This shift reflects notable improvements in key business fundamentals such as return on capital employed (ROCE), debt management, and operational efficiency. However, certain areas remain under scrutiny as the company navigates a competitive healthcare landscape. This article delves into the detailed financial metrics and quality parameters that underpin this upgrade, providing investors with a comprehensive view of the company’s evolving fundamentals.

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 May 2026, providing investors with the latest insights into its performance and outlook.